Active substance: human coagulation factor VIII / human von Willebrand factor Regulatory outcome: maintenance
Intravenous DDAVP and Factor VIII-von Willebrand Factor Concentrate for the Treatment and Prophylaxis of Bleedings in Patients W
ADMINISTRATĪVĀ APGABALTIESA SPRIEDUMS Latvijas tautas vārdā Aprakstošā daļa 66.249.65.169 22.03.2023. 21:40 Anonīms sist
Obstacles to Early Diagnosis and Treatment of Inherited von Willebrand Disease: Current Perspectives. - Document - Gale OneFile: Health and Medicine
![Lyophilized Powder Baxter Immunate Factor Viii Injection, For Hospital, 250IU at Rs 3100/box in Lucknow Lyophilized Powder Baxter Immunate Factor Viii Injection, For Hospital, 250IU at Rs 3100/box in Lucknow](https://5.imimg.com/data5/SELLER/Default/2021/8/RB/QZ/KQ/37240812/immunate-injection-baxter-250iu-500x500.jpg)
Lyophilized Powder Baxter Immunate Factor Viii Injection, For Hospital, 250IU at Rs 3100/box in Lucknow
![PDF) Severe bleeding diathesis associated with moderate thrombocytopenia - diagnostic workup of seven family members with type 2B von Willebrand's disease: LETTER TO THE EDITOR | Joanna Musiał - Academia.edu PDF) Severe bleeding diathesis associated with moderate thrombocytopenia - diagnostic workup of seven family members with type 2B von Willebrand's disease: LETTER TO THE EDITOR | Joanna Musiał - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/47953730/mini_magick20190205-2974-1r9qzcl.png?1549382908)